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Abstract: Purpose: The onset of substance use mostly occurs during adolescence. The aim of
the present study is to investigate the relevance of personality on the basis of the NEO-
Five-Factor-Inventory (NEO-FFI) to future experiences with tobacco, alcohol and
cannabis.
Methods: The test data were derived from the baseline assessment and first follow-up
of the IMAGEN study, a European multicenter and multidisciplinary research project on
adolescent mental health. In the present study 1004 participants were tested. The
characterization of personality was conducted with the NEO-FFI at the age of 14 (T1).
The data on substance use were collected with the European School Survey Project
on Alcohol and Other Drugs (ESPAD) questionnaire at the age of 16 (T2). For the
statistical analysis, t-tests and univariate analyses of variance were performed.
Results: The scores of Conscientiousness at T1 were significantly lower for
adolescents with tobacco, alcohol and cannabis experiences at T2. We found lower
scores of Agreeableness at T1 in participants with tobacco and cannabis use at T2.
Extraversion at T1 was significantly higher for adolescents with smoking experiences at
T2. No significant associations between Neuroticism or Openness and future
substance use were observed.
Conclusion: Low scores of Conscientiousness and Agreeableness seem to have the
greatest value for a prediction of later experiences with substance use. As the present
study is the first one to examine the predictive value of the NEO-FFI for future
substance use in an adolescent sample, further studies are necessary to enable a
better applicability in a clinical context.
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Predictive utility of the NEO-FFI for later substance experiences among 16-year-old adolescents 
 
Abstract 
Purpose: The onset of substance use mostly occurs during adolescence. The aim of the present study is to 
investigate the relevance of personality on the basis of the NEO-Five-Factor-Inventory (NEO-FFI) to future 
experiences with tobacco, alcohol and cannabis.  
Methods: The test data were derived from the baseline assessment and first follow-up of the IMAGEN study, a 
European multicenter and multidisciplinary research project on adolescent mental health. In the present study 
1004 participants were tested. The characterization of personality was conducted with the NEO-FFI at the age of 
14 (T1). The data on substance use were collected with the European School Survey Project on Alcohol and 
Other Drugs (ESPAD) questionnaire at the age of 16 (T2). For the statistical analysis, t-tests and univariate 
analyses of variance were performed. 
Results: The scores of Conscientiousness at T1 were significantly lower for adolescents with tobacco, alcohol 
and cannabis experiences at T2. We found lower scores of Agreeableness at T1 in participants with tobacco and 
cannabis use at T2. Extraversion at T1 was significantly higher for adolescents with smoking experiences at T2. 
No significant associations between Neuroticism or Openness and future substance use were observed. 
Conclusion: Low scores of Conscientiousness and Agreeableness seem to have the greatest value for a 
prediction of later experiences with substance use. As the present study is the first one to examine the predictive 
value of the NEO-FFI for future substance use in an adolescent sample, further studies are necessary to enable a 
better applicability in a clinical context. 
 
Keywords 
adolescence – personality – five-factor  model of personality – NEO-FFI – substance use 
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Purpose 
Adolescence is a time of essential experimenting during psychological, cognitive, psychic and emotional 
development.  In the context of many studies the early onset of substance use is indicated to be one of the most 
important predictors for future substance use, and the development of addiction (DeWit et al. 2000; Prescott and 
Kendler 2001)  and the future consumption of illicit drugs (Kandel and Yamaguchi 1993). The three most 
consumed substances in European adolescents are tobacco, alcohol and cannabis. 
The early onset of tobacco consumption may lead to addiction within only few years. Serious illnesses such as 
bronchial carcinoma, COPD and coronary heart disease as well as structural brain deficits and impaired quality 
of living may result (Centers for Disease and Prevention 2008; Gallinat et al. 2006; Kuhn et al. 2012). Moreover, 
alcohol consumption at a young age is a main risk factor for future alcohol addiction in adulthood (Grant et al. 
2006) and the development of addictions to more substances like nicotine (Dierker et al. 2013). Chronic cannabis 
consumption as well as leisure consumption during puberty can lead to lasting cognitive impairment (Battistella 
et al. 2014). Morphologic changes in the brain, for instance volume reduction of the grey matter in areas with a 
high number of CB1-receptors have been reported (Battistella et al. 2014). In this context volume reduction 
correlates to the frequency of consumption (Battistella et al. 2014). Furthermore there is evidence that suggests a 
connection between cannabis consumption, schizophrenia and certain genetic variants (De Sousa et al. 2013). A 
correlation between high consumption and onset of disorder in young age has been described (De Sousa et al. 
2013).  
The NEO Five-Factor-Model of personality is a well-validated hierarchical organization of personality traits 
using five dimensions (McCrae and John 1992). NEO is an acronym for the first three dimensions: Neuroticism 
(e.g. the disposition to experience distress, sadness), Extraversion (e.g. the disposition to be outgoing, sociable) 
and Openness (e.g. the disposition to seek new experiences, to be intellectually curious) (McCrae and John 
1992). The two additional dimensions are Agreeableness (e.g. the disposition to be cooperative, compassionate) 
and Conscientiousness (e.g. the disposition to be self-disciplined, reliable) (McCrae and John 1992). 
So far, studies suggest associations between the consumption of substances and personality (Whelan et al. 2014; 
Woicik et al. 2009). The NEO-Five-Factor-Model of personality is a widely used model to describe personality. 
Synopsis studies suggest that substance use is mainly found in participants with a high score of Neuroticism, 
Extraversion, Openness and low score of Agreeableness and Conscientiousness (Clark et al. 2012; Fridberg et al. 
2011; Malouff et al. 2007; McCann 2010; Salujha et al. 2014; Vollrath and Torgersen 2008; Waga and Iwahashi 
2007): Concerning tobacco consumption Waga and Iwahashi found significantly high scores of Openness in 
Japanese students who smoke (Waga and Iwahashi 2007). In their meta-analysis Malouff et al. revealed an 
association between alcohol consumption and high score of Neuroticism as well as low scores of Agreeableness 
and Conscientiousness (Malouff et al. 2007). So did Salujha et al. who additionally found high scores of 
Extraversion and Openness in alcohol dependent participants (Salujha et al. 2014) . In another study participants 
with high scores of Neuroticism and Extraversion did not only drink more alcohol than other participants but 
were also more prone to taking illicit drugs (Vollrath and Torgersen 2008). High scores of Openness and low 
scores of Agreeableness and Conscientiousness were revealed by Fridberg et al. in cannabis smokers (Fridberg et 
al. 2011). 
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While there exist many cross-sectional studies there is little literature concerning the predictive value of 
personality and substance use: Pluess and Bartley collected data suggesting high scores of Conscientiousness in 
adolescence to be a significant predictor for low tobacco smoking at the age of 50 (Pluess and Bartley 2015). 
Zvolensky et al. revealed high scores of Neuroticism and Openness as predictors for tobacco smoking within ten 
years in an US sample, whereas high scores of Conscientiousness seemed to be a protective factor for tobacco 
smoking or the development of occasional smoking to habitual smoking (Zvolensky et al. 2015). 
Since most studies have a cross-sectional design, they focus on the association between the scores of the five 
dimensions of the NEO Five-Factor-Model of personality and substance use (Clark et al. 2012; Fridberg et al. 
2011; Malouff et al. 2007; McCann 2010; Salujha et al. 2014; Vollrath and Torgersen 2008; Waga and Iwahashi 
2007). Only few longitudinal studies exist with the focus on the predictive value of these dimensions for later 
substance use. The present study is the first one to examine this topic in a European 14 to 16-years-old sample, 
since at that age the onset of smoking, alcohol and cannabis consumption mostly occurs. 
 
Methods 
Participants 
The test data were derived from the baseline assessment and first follow-up of the IMAGEN-Study, a European 
multicenter and multidisciplinary research project on adolescent mental health, under consideration of 
personality traits, brain activity and genetic predisposition (Schumann et al. 2010). The study started in 
December 2007 at eight study centers in England (London, Nottingham), Ireland (Dublin), France (Paris) and 
Germany (Berlin, Mannheim, Dresden, Hamburg). Follow-up examinations were performed at intervals of two 
and four years after the baseline assessment. The participants’ recruitment took place in secondary schools and 
was based on two criteria: 1) Greatest possible diversity in terms of socio-economic status, cognitive and 
emotional development, 2) minimization of the ethnic heterogeneity by selecting a sample of young people with 
European ethnicity (Schumann et al. 2010).  
For the present investigation, only the data of the baseline assessment (=T1) and first follow-up (=T2) were 
analyzed and only those participants were considered, who had completed the NEO Five-Factor-Inventory and 
ESPAD questionnaire: Those were 998 participants, 530 (53.1%) of them were males and 468 females. The 
average age at the baseline assessment was 14 years ± 3 months and at the first follow-up 16 years ± 3 months. 
 
NEO Five-Factor-Inventory 
The NEO Five-Factor-Inventory was adapted for the IMAGEN study and was part of a computerized test battery 
that the participants performed at each research institute using Psytools, Delosis UK. Participants rated how 
much each one of the 60 items applied to them on a Likert-scale ranging from “strongly agree” to “strongly 
disagree”. Total scores for each dimension were derived from each participant’s responses to the 12 items for 
each dimension ranging from 12 points to 60 points (McCrae and John 1992). 
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ESPAD 
The by the European School Survey Project on Alcohol and other Drugs developed ESPAD questionnaire was 
also adapted for the IMAGEN study and part of the computerized test battery using Psytools, Delosis UK. The 
ESPAD questionnaire is widely used for international studies on prevalence of substance use and drug abuse 
among children and adolescents (Hibell et al. 2000; Hibell et al. 2004). In the present study three items were 
used, asking about the lifetime prevalence of tobacco, alcohol and cannabis consumption with the aim to 
distinguish adolescents with and without experiences with each substance.  
Statistical analysis 
IBM SPSS Statistics 21 for Windows was used for the analysis of the study data. The division of the mean scores 
of each dimension of the NEO Five-Factor-Model by their medians showed a normal distribution for each 
dimension. Therefore we used t-tests after alpha-adjustment via Bonferroni correction (p=0.0083) and ANOVA. 
Ethics 
The study protocol was approved by the local ethic boards of all study partners. Written informed consent was 
obtained from all legal guardians and assent was obtained from the adolescents.  
 
Results 
Participants came from three different nations: 432 from Germany (43%), 423 from Great Britain (42%) and 143 
from Ireland (15%). On a percentage basis, at the age of 16 German participants had more experiences with 
tobacco, alcohol or cannabis. A significant difference could be found in experiences with tobacco (F=7.822, 
p<0.001) and alcohol (F=12.266, p<0.001) in German and British adolescents. Participants’ experiences with 
substances at the age of 16 are shown in Figure 1.  
Male and female participants were equally experienced. 
As shown in Figure 2-4, analysis of NEO-FFI scores revealed that the mean scores of Neuroticism and 
Extraversion at T1 were higher for substance-experienced participants as compared to unexperienced 
participants at T2. However, a significant difference could only be found for Extraversion and tobacco smoking 
(t=3.357, p<0.001). Mean scores for Agreeableness at T1 in participants with substance experience at T2 were 
lower as compared in participants without experiences, which showed a significant difference in tobacco (t=-
5.206, p<0.001) and cannabis experience (t=-2.806, p=0.005). Mean scores for Conscientiousness at T1 were 
significantly lower for all substance experienced participants as compared to unexperienced at T2 (t=-5.988, 
p<0.001; t=-3.804, p<0.001; t=-4.186, p<0.001). Mean scores for Openness at T1 did not differ significantly on 
participants with or without substance experiences at T2 and were lower in participants with tobacco experiences 
and higher in participants with alcohol and cannabis experiences, see Table 1. 
 
Discussion 
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In our analysis on a large cohort of 998 adolescents, we found low scores of Agreeableness in 14-year-olds with 
later substance experiences, being significant with tobacco smoking and cannabis experiences as shown in Table 
2. In terms of the Five Factor Model of personality, Agreeableness reflects a disposition to cooperation and 
compassionate as well as positive attitudes towards others (McCrae and John 1992). As these are attributes not 
commonly associated with substance users, a low score of Agreeableness in smokers and cannabis users in the 
present study was expected. The individual interest to consume a substance is placed first before interests of 
others. Furthermore, we found that a low score of Conscientiousness at the age of 14 is a significant predictive 
factor for experiences with all three substances at the age of 16. As Conscientiousness measures the level of self-
discipline and reliability, a low score seems to imply that participants are more prone to trying out substances. 
This is supported by the findings in the present study as well in other studies (Pluess and Bartley 2015; 
Zvolensky et al. 2015).While for low scores of Conscientiousness Pluess and Bartley as well as Zvolensky et al. 
revealed the predictive value for later substance use, for low scores of Agreeableness Mallouff et al. as well as 
Salujha et al. and Fridberg et al. could only reveal an association, no study – as far as known - showed 
Agreeableness to be a predictive factor. Concomitant, several studies revealed an association between low scores 
of Conscientiousness and substance use (Fridberg et al. 2011; Malouff et al. 2007; Salujha et al. 2014), 
suggesting Conscientiousness being the most important predictive value of the dimensions of the NEO Five-
Factor-Model of personality for later substance use and being an important factor for maintaining substance use.  
We observed higher scores of Neuroticism in 14-year-olds who had substance experiences at the age of 16. 
These results were not significant however, as they were for Malouff et al. in tobacco smokers (Malouff et al. 
2007) and for Salujha in alcohol dependent participants (Salujha et al. 2014) as well as Vollrath and Torgersen in 
alcohol consumers (Vollrath and Torgersen 2008). As these are cross-sectional studies, the results suggest that 
Neuroticism plays an important role in maintaining substance use but not necessarily in developing it. However, 
Zvolensky et al. found a significant coherence at high scores of Neuroticism and developing tobacco smoking 
examining an adult sample double the size of the present study (Zvolensky et al. 2015). High scores of 
Neuroticism indicate that participants tend to experience distress or sadness more often. Distress is one of the 
main reasons to initiate substance use as Hyman and Sinha found out for cannabis use (Hyman and Sinha 2009). 
Substance use might be used for emotional modulation. However, these findings cannot be supported by the 
present study with an adolescent cohort. As Salujha et al. and Vollrath and Torgersen, we found high scores of 
Extraversion in substance-experienced participants (Salujha et al. 2014; Vollrath and Torgersen 2008). However, 
our results were significant with tobacco smoking but not with cannabis or alcohol experiences. In alcohol abuse, 
level of sensitivity to alcohol rather than personality factors predict intake during adolescence (Hinckers et al. 
2006). As Extraversion describes the disposition to be outgoing and sociable, participants with a high score on 
this dimension presumably can report of an easier availability of substances. These individuals can find 
stimulation in substance use in a social context such as smoking tobacco. While we could not reveal Openness to 
be a predictive factor for later substance experiences, several authors found an association between high scores 
of Openness and substance use (Fridberg et al. 2011; Salujha et al. 2014; Waga and Iwahashi 2007). Participants 
with a high score on Openness are curious for new experiences which they might find in the consumption of 
substances. Again, we refer to the cross-sectional designs of the other studies and smaller, adult samples as 
compared to our adolescent cohort. 
Strengths and limitations 
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In the present study we used the NEO-FFI and ESPAD questionnaire which are retrospective instruments 
requiring participants’ solid memory and truthful answers. However, being part of a computerized battery of 
questionnaires to be answered at home participants were able to take as much time as needed in a domestic 
environment. 
A remarkable feature of the present work is the size and international nature of the study population with 
participants from different socio-economic backgrounds and developmental stages, presumably enabling the 
transfer of the results to a large part of European adolescents. However, only Caucasian adolescents were 
included so that a reliable transfer of the findings is limited to only this ethnic group. An extension of the study 
to other continents and ethnic groups may reveal further results and also allow regional comparisons. 
Considering future research projects, the longitudinal design of the IMAGEN study is another significant 
strength enabling tracking of cognitive and behavioral changes until adulthood and identifying predictive factors 
for later behaviours such as substance use. 
 
Conclusion 
The present study presents an investigation analyzing the predictive value of the NEO-FFI for the development 
of substance use on an adolescent European sample. 
At this time, the NEO-FFI cannot be used as an ultimate predictive instrument for future substance experiences. 
However, a low score of Conscientiousness was the most important factor for a prediction of later experiences 
with substances in this study. Future studies should ascertain the causality of personality for substance use for 
the development of individual strategies for prevention and treatment of substance use and potential substance-
related addiction. 
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Figure 1 Experiences with substances at T2 
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Figure 2 NEO-FFI dimension scores for tobacco experienced (n=472) and unexperienced (n=526) participants 
** p<0.001, t-test 
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Figure 3 NEO-FFI dimension scores for alcohol experienced (n=911) and unexperienced (n=87) participants 
** p<0.001, t-test 
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Figure 4 NEO-FFI dimension scores for cannabis experienced (n=241) and unexperienced (n=757) participants 
*p<0.0083 ** p<0.001, t-test 
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Table 1 NEO-FFI dimension scores for substance experienced and unexperienced participants 
 Factors Mean (SD) t-value Cohen’s d 
  Experienced Unexperienced   
Tobacco 
Neuroticism 23.16 (7.59) 22.35 (7.13) 1.726 -0.11 
Extraversion 30.73 (5.76) 29.51 (5.74) 3.357 -0.24 
Openness 26.20 (6.05) 26.41 (5.92) -0.548 0.035 
Agreeableness 28.16 (5.44) 29.91 (5.17) -5.206 0.33 
Conscientiousness 26.20 (6.29) 28.70 (6.85) -5.988 0.379 
Alcohol 
Neuroticism 22.78 (7.39) 22.20 (7.13) 0.712 -0.085 
Extraversion 30.14 (5.73) 29.58 (6.28) 0.864 -0.09 
Openness 26.37 (6.02) 25.63 (5.53) 1.101 -0.133 
Agreeableness 28.98 (5.42) 30.09 (4.75) -1.843 0.231 
Conscientiousness 27.27 (6.66) 30.12 (6.68) -3.804 0.433 
Cannabis 
Neuroticism 22.78 (7.50) 22.72 (7.32) 0.105 -0.008 
Extraversion 30.81 (6.01) 29.86 (5.69) 2.248 -0.165 
Openness 27.07 (6.15) 26.06 (5.91) 2.282 -0.169 
Agreeableness 28.24 (5.14) 29.35 (5.42) -2.806 0.207 
Conscientiousness 25.96 (6.51) 28.02 (6.39) -4.186 0.321 
 
Table
Table 2 Score of dimensions in participants with substance experiences as compared to unexperienced 
participants. 
* p>0.0086 **p<0.001, t-test 
 
Factor tobacco alcohol cannabis 
Neuroticism ↑ ↑ ↑ 
Extraversion ↑** ↑ ↑ 
Openness ↓ ↑ ↑ 
Agreeableness ↓** ↓ ↓* 
Conscientiousness ↓** ↓** ↓** 
 
Table
